Alethia BioTherapeutics alethiabio.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Alethia BioTherapeutics is a biotechnology company that develops monoclonal antibody therapeutics to clinically relevant targets identified using its STAR discovery technology.

Alethia BioTherapeutics is a biotechnology company that develops monoclonal antibody therapeutics to clinically relevant targets identified using its STAR discovery technology.

Company (Alive / Active)

Phone: 514-858-7666

Fax: 514-858-7666

141, Président-Kennedy Ave
Suite SB-5100
Montreal, H2X 1Y4
Quebec, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Alethia BioTherapeutics $16.2M Nov 1, 2012
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Alethia BioTherapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors

Competitors

Company Status Description Investors

Amicus Therapeutics

Cranbury, New Jersey, United States
IPO / Went publicAmicus (NASDQ:FOLD) is a biopharmaceutical company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases.Login to see details

Spaltudaq

Seattle, Washington, United States
Alive / ActiveSpaltudaq Corporation, a privately-held biotechnology company based in Seattle, is focused on developing therapeutic antibodies for the treatment of inflammation, infectious disease and cancer. Our technology harnesses the power of the human immune system to identify tumor-specific or pathogen-specific monoclonal antibodies from human tissue samples.Login to see details
See all 16 competitors